Stanley Chang
Chief Executive Officer chez MEDIGEN BIOTECHNOLOGY CORP.
Profil
Shih Chung Chang is currently the Chairman & Chief Executive Officer at Medigen Biotechnology Corp., Chairman at Winston Medical Supply Co., Ltd., and Chairman at Medigen Vaccine Biologics Corp.
He is also a Director at TBG Diagnostics Ltd., TBG, Inc. (Taiwan), TBG Biotechnology, Inc., and UMO International Co., Ltd.
Previously, he served as a Director at the Development Center for Biotechnology and Medigreen Biotechnology Corp.
He was also the President of Ameribankers Corp.
from 2000 to 2000.
Additionally, he worked as a Professor at Tzu Chi University.
Dr. Chang holds a doctorate degree from University College London and an undergraduate degree from National Taiwan University College of Medicine.
Postes actifs de Stanley Chang
| Sociétés | Poste | Début |
|---|---|---|
| TBG DIAGNOSTICS LIMITED | Director/Board Member | - |
| MEDIGEN BIOTECHNOLOGY CORP. | Chief Executive Officer | 09/06/2003 |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chairman | 12/12/2012 |
| WINSTON MEDICAL SUPPLY CO., LTD. | Chairman | 07/02/2014 |
| TBG Biotechnology, Inc. | Director/Board Member | - |
| UMO International Co., Ltd. | Director/Board Member | - |
TBG, Inc. (Taiwan)
 TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Director/Board Member | - |
Anciens postes connus de Stanley Chang
| Sociétés | Poste | Fin |
|---|---|---|
| Ameribankers Corp. | President | 01/01/2000 |
Development Center for Biotechnology
 Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
| ░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Stanley Chang
| University College London | Doctorate Degree |
| National Taiwan University College of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MEDIGEN BIOTECHNOLOGY CORP. | Health Technology |
| WINSTON MEDICAL SUPPLY CO., LTD. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| Entreprise privées | 7 |
|---|---|
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Finance |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
| Ameribankers Corp. | |
Medigreen Biotechnology Corp.
 Medigreen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Medigreen Biotechnology Corporation, founded on April 10th, 2002, is focusing on the development of botanical new drugs and is established by domestic and overseas outstanding enterprises and entrepreneurs, in accordance with the government's promotion policy, to develop the Chinese Traditional Medicine industry. The major stockholders of Medigreen include Medigen Biotechnology Corp., SunTen Phytotech Co., Ltd. and YFY Biotech Management Company, etc. Since the foundation, based on the mission of 'contribution to the human health' and on the main principle of the immunologic system, Medigreen has been worked on the R & D of new botanical drugs on 'cancer adjuvant', 'anti-ulcer' and 'respiratory tract diseases'. Medigreen develops diverse functional products and ingredients on the base of the Traditional Chinese Medicine theory, the concept of 'medicine and food from the same source', and the efficacy examination of biotechnology followed the new drug development process to contribute to the human health and to guarantee the persistent progress of the enterprise during the new drug development. | Health Technology |
| TBG Biotechnology, Inc. | |
| UMO International Co., Ltd. |
